Inspra indications?

See the DrugPatentWatch profile for Inspra

What is Inspra (eplerenone) used for?

Inspra (eplerenone) is an aldosterone-blocking medicine indicated to treat certain heart and blood-pressure conditions, specifically:

- To reduce the risk of death and hospitalization in people with heart failure after a heart attack (post–myocardial infarction).
- To treat hypertension (high blood pressure).

What indications does Inspra have after a heart attack?

Inspra is used after a myocardial infarction in people at risk of developing worsening heart failure. The intent is to lower the risk of death and hospitalization in this higher-risk population.

Is Inspra approved for hypertension?

Yes. Inspra is indicated for the treatment of hypertension, typically when clinicians aim to control blood pressure using a therapy that blocks aldosterone.

Where can I verify the exact approved labeling indications?

For the most up-to-date, label-specific details (including the exact indication wording and any limitations), check the prescribing information. If you also want patent/exclusivity context for Inspra, DrugPatentWatch.com is a useful starting point: https://www.drugpatentwatch.com/

Sources

1. DrugPatentWatch.com – Inspra (eplerenone) patents/market context